BRPI0911743A2 - "peptídeo" - Google Patents

"peptídeo"

Info

Publication number: BRPI0911743A2
Authority: BR; Brazil
Prior art keywords: peptide
Prior art date: 2008-07-24

Application number

BRPI0911743-1A

Other languages

English (en)

Inventor

Cristina Carreno Serraima

Wim Van Den Nest

Antonio Ferrer Montiel

Maria Camprubi Robes

Jimena Fernandez Carneado

Berta Ponsati Obliols

Original Assignee

Bcn Peptides Sa

Diverdrugs Sl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-07-24

Filing date

2009-07-24

Publication date

2015-07-07

2009-07-24 Application filed by Bcn Peptides Sa, Diverdrugs Sl filed Critical Bcn Peptides Sa

2015-07-07 Publication of BRPI0911743A2 publication Critical patent/BRPI0911743A2/pt

2021-11-16 Publication of BRPI0911743B1 publication Critical patent/BRPI0911743B1/pt

Links

108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Toxicology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Birds (AREA)
Cell Biology (AREA)
Materials Engineering (AREA)
Hematology (AREA)
Rheumatology (AREA)
Marine Sciences & Fisheries (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Cosmetics (AREA)
Medicinal Preparation (AREA)

BRPI0911743-1A 2008-07-24 2009-07-24 Uso de um peptídeo BRPI0911743B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ES200802210A ES2356883B1 (es)	2008-07-24	2008-07-24	Composición para el tratamiento del dolor y/o la inflamación.
ESP200802210		2008-07-24
PCT/EP2009/005381 WO2010009892A2 (en)	2008-07-24	2009-07-24	Compositions for the treatment of pain and/or inflamation

Publications (2)

Publication Number	Publication Date
BRPI0911743A2 true BRPI0911743A2 (pt)	2015-07-07
BRPI0911743B1 BRPI0911743B1 (pt)	2021-11-16

Family

ID=41462205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0911743-1A BRPI0911743B1 (pt)	2008-07-24	2009-07-24	Uso de um peptídeo

Country Status (24)

Country	Link
US (2)	US20110206752A1 (pt)
EP (1)	EP2318033B8 (pt)
JP (1)	JP5920916B2 (pt)
KR (1)	KR20110056491A (pt)
CN (1)	CN102164610B (pt)
AR (1)	AR072610A1 (pt)
AU (1)	AU2009273471C1 (pt)
BR (1)	BRPI0911743B1 (pt)
CA (1)	CA2731880C (pt)
CY (1)	CY1121125T1 (pt)
DK (1)	DK2318033T3 (pt)
ES (2)	ES2356883B1 (pt)
HR (1)	HRP20190059T1 (pt)
HU (1)	HUE042083T2 (pt)
IL (1)	IL210810B (pt)
LT (1)	LT2318033T (pt)
MX (1)	MX2011000868A (pt)
PL (1)	PL2318033T3 (pt)
PT (1)	PT2318033T (pt)
RU (1)	RU2515054C2 (pt)
SG (1)	SG192548A1 (pt)
SI (1)	SI2318033T1 (pt)
TR (1)	TR201900542T4 (pt)
WO (1)	WO2010009892A2 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2961510A1 (fr) *	2010-06-17	2011-12-23	Oreal	Utilisation comme agent de traitement de la transpiration humaine ; nouveaux derives d'acide amine ; compositions les contenant
ES2385683B1 (es) *	2010-10-18	2013-10-07	Bcn Peptides, S.A.	Composiciones para el tratamiento del dolor y/o la inflamación.
DK3415157T3 (da)	2011-10-28	2020-10-19	Neostrata Company Inc	N-acyldipeptidderivater og anvendelser deraf
WO2013070808A1 (en)	2011-11-07	2013-05-16	Feng Tian	Peptide-based compounds as inhibitors of neurotransmitter secretion
US9687669B2 (en)	2011-11-09	2017-06-27	John Stephan	Wearable light therapy apparatus
CA2859915A1 (en) *	2012-01-03	2013-07-11	Ruey J. Yu	N-acylpeptide derivatives and their uses
EP2649984A1 (en)	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis
EP2649983A1 (en)	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis (II)
ES2660901T3 (es)	2012-04-13	2018-03-26	Lubrizol Advanced Materials, Inc.	Compuestos que inhiben la exocitosis neuronal (II)
EP2649985A1 (en)	2012-04-13	2013-10-16	Lipotec, S.A.	Compounds which inhibit neuronal exocytosis (III)
DE102014007423A1 (de) *	2014-05-22	2015-11-26	Bitop Ag	Zusammensetzung zur Behandlung des Auges
RU2580280C2 (ru) *	2014-07-08	2016-04-10	Общество с ограниченной ответственностью "НИТРОЗДРАВ"	Композиция для местного применения для снижения или снятия болевого синдрома
GB201505527D0 (en)	2015-03-31	2015-05-13	Jmedtech Pte Ltd	Composition
US20190083809A1 (en)	2016-07-27	2019-03-21	Z2020, Llc	Componentry and devices for light therapy delivery and methods related thereto
JP7227903B2 (ja) *	2016-11-30	2023-02-22	ルブリゾルアドバンスドマテリアルズ，インコーポレイテッド	皮膚、毛髪、爪および／もしくは粘膜の処置ならびに／またはケアに有用な化合物
KR102293250B1 (ko) *	2017-09-18	2021-08-26	애니젠 주식회사	활성물질-헥사펩타이드 복합체 및 이를 포함하는 화장료 조성물
EP3691618A1 (en)	2017-10-06	2020-08-12	Foundry Therapeutics, Inc.	Implantable depots for the controlled release of therapeutic agents
CN116650732A (zh)	2018-01-08	2023-08-29	铸造疗法股份有限公司	经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
US12458589B2 (en)	2018-05-12	2025-11-04	Foundry Therapeutics, Inc.	Implantable polymer depots for the controlled release of therapeutic agents
WO2019224184A1 (en)	2018-05-21	2019-11-28	Ipsen Biopharm Limited	Suppression of bone cancer-induced allodynia
ES3060502T3 (en)	2018-06-13	2026-03-26	Acraf	Peptides having inhibitory activity on neuronal exocytosis
EP3843710A1 (en)	2018-08-28	2021-07-07	Foundry Therapeutics, Inc.	Polymer implants
WO2020182970A1 (en)	2019-03-14	2020-09-17	Om Pharma Sa	Process for making stable bacterial extracts and their use as pharmaceuticals
WO2020259447A1 (zh)	2019-06-24	2020-12-30	湖南方升泰医药科技有限公司	金属络合物的新应用
CN116731111A (zh) *	2022-10-14	2023-09-12	深圳市维琪科技股份有限公司	合成肽及其组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4179337A (en) *	1973-07-20	1979-12-18	Davis Frank F	Non-immunogenic polypeptides
US6974578B1 (en) *	1993-12-28	2005-12-13	Allergan, Inc.	Method for treating secretions and glands using botulinum toxin
ATE215832T1 (de) *	1994-05-09	2002-04-15	William J Binder	Botulinumtoxin zur reduktion von migraine - kopfschmerzen
US6169074B1 (en) *	1996-03-18	2001-01-02	The Regents Of The University Of California	Peptide inhibitors of neurotransmitter secretion by neuronal cells
ES2160485B1 (es) *	1999-04-23	2002-05-16	Lipotec Sa	Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
US6113915A (en) *	1999-10-12	2000-09-05	Allergan Sales, Inc.	Methods for treating pain
US6500436B2 (en) *	2000-01-19	2002-12-31	Allergan, Inc.	Clostridial toxin derivatives and methods for treating pain
US6641820B1 (en) *	2000-01-19	2003-11-04	Allergan, Inc.	Clostridial toxin derivatives and methods to treat pain
US6464986B1 (en) *	2000-04-14	2002-10-15	Allegan Sales, Inc.	Method for treating pain by peripheral administration of a neurotoxin
US6565870B1 (en) *	2000-04-28	2003-05-20	Allergan, Inc.	Methods for treating bone tumors
US6423319B1 (en) *	2000-10-04	2002-07-23	Allergan Sales, Inc.	Methods for treating muscle injuries
GB0111146D0 (en) *	2001-05-04	2001-06-27	Imp College Innovations Ltd	Methods
US6623742B2 (en) *	2001-09-17	2003-09-23	Allergan, Inc.	Methods for treating fibromyalgia
US7255866B2 (en) *	2001-09-17	2007-08-14	Allergan, Inc.	Botulinum toxin therapy for fibromyalgia
US7071167B2 (en) *	2002-11-13	2006-07-04	L'oreal	Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
US6838434B2 (en) *	2003-05-02	2005-01-04	Allergan, Inc.	Methods for treating sinus headache
GB2416122A (en) *	2004-07-12	2006-01-18	Ipsen Ltd	Botulinum neurotoxin composition
ES2362301T3 (es) *	2005-03-03	2011-07-01	Revance Therapeutics, Inc.	Composiciones y procedimientos para aplicaciones tópicas y liberación transdérmica de un oligopéptido.
CN102408470A (zh) *	2005-12-23	2012-04-11	洛桑大学	用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽
GB0602992D0 (en) *	2006-02-15	2006-03-29	Morvus Technology Ltd	Methods, genes and proteins
FR2902341B1 (fr) *	2006-06-16	2011-02-25	Scras	Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
ES2322882B1 (es) *	2006-10-25	2010-04-22	Lipotec Sa	Peptidos inhibidores de la exocitosis neuronal.
KR20090041066A (ko) *	2007-10-23	2009-04-28	성균관대학교산학협력단	신경전달물질 배출을 조절하는 합성 펩타이드

2008
- 2008-07-24 ES ES200802210A patent/ES2356883B1/es active Active
2009
- 2009-07-24 MX MX2011000868A patent/MX2011000868A/es active IP Right Grant
- 2009-07-24 JP JP2011519085A patent/JP5920916B2/ja active Active
- 2009-07-24 TR TR2019/00542T patent/TR201900542T4/tr unknown
- 2009-07-24 SI SI200931917T patent/SI2318033T1/sl unknown
- 2009-07-24 ES ES09777419T patent/ES2714357T3/es active Active
- 2009-07-24 US US13/055,598 patent/US20110206752A1/en not_active Abandoned
- 2009-07-24 CN CN200980137382.XA patent/CN102164610B/zh active Active
- 2009-07-24 BR BRPI0911743-1A patent/BRPI0911743B1/pt active IP Right Grant
- 2009-07-24 PL PL09777419T patent/PL2318033T3/pl unknown
- 2009-07-24 HU HUE09777419A patent/HUE042083T2/hu unknown
- 2009-07-24 CA CA2731880A patent/CA2731880C/en active Active
- 2009-07-24 EP EP09777419.4A patent/EP2318033B8/en active Active
- 2009-07-24 AU AU2009273471A patent/AU2009273471C1/en active Active
- 2009-07-24 RU RU2011105280/04A patent/RU2515054C2/ru active
- 2009-07-24 AR ARP090102843A patent/AR072610A1/es unknown
- 2009-07-24 SG SG2013055900A patent/SG192548A1/en unknown
- 2009-07-24 PT PT09777419T patent/PT2318033T/pt unknown
- 2009-07-24 WO PCT/EP2009/005381 patent/WO2010009892A2/en not_active Ceased
- 2009-07-24 KR KR1020117004108A patent/KR20110056491A/ko not_active Ceased
- 2009-07-24 DK DK09777419.4T patent/DK2318033T3/en active
- 2009-07-24 LT LTEP09777419.4T patent/LT2318033T/lt unknown
- 2009-07-24 HR HRP20190059TT patent/HRP20190059T1/hr unknown
2011
- 2011-01-23 IL IL210810A patent/IL210810B/en active IP Right Grant
2018
- 2018-12-27 US US16/233,378 patent/US20190184054A1/en not_active Abandoned
2019
- 2019-01-15 CY CY191100041T patent/CY1121125T1/el unknown

Also Published As

Publication number	Publication date
AU2009273471B2 (en)	2014-04-17
EP2318033A2 (en)	2011-05-11
LT2318033T (lt)	2019-02-11
CN102164610A (zh)	2011-08-24
EP2318033B8 (en)	2019-02-27
CY1121125T1 (el)	2019-12-11
AU2009273471C1 (en)	2014-08-21
WO2010009892A2 (en)	2010-01-28
CA2731880A1 (en)	2010-01-28
MX2011000868A (es)	2011-06-09
DK2318033T3 (en)	2019-02-04
HRP20190059T1 (hr)	2019-03-08
SG192548A1 (en)	2013-08-30
BRPI0911743B1 (pt)	2021-11-16
ES2714357T3 (es)	2019-05-28
RU2011105280A (ru)	2012-08-27
KR20110056491A (ko)	2011-05-30
PT2318033T (pt)	2019-01-24
US20190184054A1 (en)	2019-06-20
AR072610A1 (es)	2010-09-08
TR201900542T4 (tr)	2019-02-21
EP2318033B1 (en)	2018-10-17
WO2010009892A8 (en)	2011-02-24
RU2515054C2 (ru)	2014-05-10
ES2356883B1 (es)	2012-02-22
JP5920916B2 (ja)	2016-05-18
AU2009273471A1 (en)	2010-01-28
US20110206752A1 (en)	2011-08-25
CA2731880C (en)	2016-12-13
ES2356883A1 (es)	2011-04-14
IL210810A0 (en)	2011-04-28
IL210810B (en)	2018-04-30
WO2010009892A3 (en)	2010-05-14
SI2318033T1 (sl)	2019-02-28
PL2318033T3 (pl)	2019-04-30
CN102164610B (zh)	2014-04-09
JP2011528678A (ja)	2011-11-24
HUE042083T2 (hu)	2019-06-28

Legal Events

Date	Code	Title	Description
2016-02-10	B25A	Requested transfer of rights approved	Owner name: BCN PEPTIDES, S.A. (ES)
2018-03-27	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2020-01-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-27	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-12-08	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2021-06-01	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-07-06	B06J	Correction of requirement [chapter 6.10 patent gazette]	Free format text: REFERENCIA: RPI 2630 DE 01.06.2021 - CODIGO 6.1
2021-10-19	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-11-16	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/07/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

Publication	Publication Date	Title
BRPI0910229A2 (pt)	2015-09-01	Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
EP2332943A4 (en)	2012-03-14	NOVEL CONDENSATE AMINODIHYDROTHIAZINE DERIVATIVE
BRPI0913806A2 (pt)	2015-10-20	"composição"
BRPI0922904A2 (pt)	2018-05-29	"compostos"
BRPI0914533A2 (pt)	2015-12-15	"métodos"
DK3118220T3 (da)	2019-09-23	Protein
EP2215246A4 (en)	2011-08-10	PROTEIN SCAFFOLDS
BR112012012872A2 (pt)	2017-10-10	"pirrolindinas de espiroindolinona"
EP2280916A4 (en)	2014-07-23	HYDROCHLORFLUOROLEFINZUSAMMENSETZUNGEN
BRPI0916123A2 (pt)	2015-11-03	"composição de xampu concentrada"
BRPI0814971A2 (pt)	2015-02-03	Proteína
BRPI0916129A2 (pt)	2018-05-15	"reforço"
BRPI0914503A2 (pt)	2016-01-12	"composição de shampoo concentrado"
BRPI0907062A2 (pt)	2015-07-07	"hidrociclone"
EP2258697A4 (en)	2011-08-03	HYDROXYCHINOXALINCARBOXAMIDDERIVAT
EP2280988A4 (en)	2011-08-10	ANGIOGENIC PEPTIDE
DK2021364T3 (da)	2014-07-07	Forbedrede antimikrobielle peptider
MA30860B1 (fr)	2009-11-02	Myrtillier denomme "c97-390"
FR2936764B1 (fr)	2010-11-05	Couloir d'intercirculation
EP2370100A4 (en)	2013-05-22	PEPTIDE AGENTS
BRPI0913759A2 (pt)	2019-09-24	"motor"
DK2081952T3 (da)	2014-04-28	Peptider
BRPI1013017A2 (pt)	2016-03-29	"17beta-alquil-17alfa-óxi-estratrienos"
BRPI0906321A2 (pt)	2015-07-07	"multienzima"
FI20075483A0 (fi)	2007-06-25	Uusi peptidi